BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fitting S, McRae M, Hauser KF. Opioid and neuroHIV Comorbidity - Current and Future Perspectives. J Neuroimmune Pharmacol 2020;15:584-627. [PMID: 32876803 DOI: 10.1007/s11481-020-09941-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Lark ARS, Silva LK, Nass SR, Marone MG, Ohene-Nyako M, Ihrig TM, Marks WD, Yarotskyy V, Rory McQuiston A, Knapp PE, Hauser KF. Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons Exposed to HIV-1 Tat and Morphine. Cell Mol Neurobiol 2022. [PMID: 35695980 DOI: 10.1007/s10571-022-01232-5] [Reference Citation Analysis]
2 McLane VD, Lark ARS, Nass SR, Knapp PE, Hauser KF. HIV-1 Tat reduces apical dendritic spine density throughout the trisynaptic pathway in the hippocampus of male transgenic mice. Neurosci Lett 2022;:136688. [PMID: 35595189 DOI: 10.1016/j.neulet.2022.136688] [Reference Citation Analysis]
3 Sang J, Patton RA, Park I. Comparing Perceptions of Addiction Treatment between Professionals and Individuals in Recovery. Subst Use Misuse 2022;57:983-94. [PMID: 35373710 DOI: 10.1080/10826084.2022.2058706] [Reference Citation Analysis]
4 Lin CH, Tao PL, Tsay HJ, Chiang YC, Chang WT, Ho IK, Shie FS. Dextromethorphan Dampens Neonatal Astrocyte Activation and Endoplasmic Reticulum Stress Induced by Prenatal Exposure to Buprenorphine. Behav Neurol 2021;2021:6301458. [PMID: 34336001 DOI: 10.1155/2021/6301458] [Reference Citation Analysis]
5 Marks WD, Paris JJ, Barbour AJ, Moon J, Carpenter VJ, McLane VD, Lark ARS, Nass SR, Zhang J, Yarotskyy V, McQuiston AR, Knapp PE, Hauser KF. HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure. eNeuro 2021;8:ENEURO. [PMID: 33782102 DOI: 10.1523/ENEURO.0547-20.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nicol MR, McRae M. Treating viruses in the brain: Perspectives from NeuroAIDS. Neurosci Lett 2021;748:135691. [PMID: 33524474 DOI: 10.1016/j.neulet.2021.135691] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lin Y, He JJ, Sorensen R, Chang L. Unraveling neuroHIV in the Presence of Substance Use Disorders. J Neuroimmune Pharmacol 2020;15:578-83. [PMID: 33215327 DOI: 10.1007/s11481-020-09967-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ohene-Nyako M, Nass SR, Hahn YK, Knapp PE, Hauser KF. Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice. Neurosci Lett 2021;741:135502. [PMID: 33202259 DOI: 10.1016/j.neulet.2020.135502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]